Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.900
-0.068 (-7.05%)
At close: Apr 28, 2026, 4:00 PM EDT
0.901
+0.001 (0.06%)
After-hours: Apr 28, 2026, 6:04 PM EDT
Oncolytics Biotech Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Oncolytics Biotech stock have an average target of 7.33, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 714.08% from the current stock price of 0.90.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 17, 2025.
Analyst Ratings
The average analyst rating for Oncolytics Biotech stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +1,010.62% | Nov 17, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +677.43% | Aug 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +455.31% | May 21, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $3 | Strong Buy | Maintains | $5 → $3 | +233.19% | Mar 10, 2025 |
Financial Forecast
Revenue This Year
2.02M
Revenue Next Year
52.62M
from 2.02M
Increased by 2,505.00%
EPS This Year
-0.35
from -0.30
EPS Next Year
-0.27
from -0.35
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 6.3M | 109.4M | |||||
| Avg | 2.0M | 52.6M | |||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | - | 5,316.3% | |||||
| Avg | - | 2,505.0% | |||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.29 | -0.13 |
| Avg | -0.35 | -0.27 |
| Low | -0.38 | -0.41 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.